Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
基本信息
- 批准号:9265230
- 负责人:
- 金额:$ 7.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-17 至 2017-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAgonistAndrogensAnimalsArchitectureBiocompatible MaterialsBiological AssayBiological ProcessBiologyBlood CirculationCell CommunicationCell Culture TechniquesCell LineCell LineageCell surfaceCellsCervix UteriClinical TrialsCoculture TechniquesComplexDevelopmentDiffusionDrug Delivery SystemsDrug KineticsDrug toxicityEndocrineEndocrine DisruptorsEndometriumEnvironmentEstrogensEvaluationExocervixExposure toFeedbackFemaleFertilityFertilizationFetal DevelopmentFollicle Stimulating HormoneFunctional disorderFundingGerm CellsGoalsGrantHealthHormonalHormonesHospitalsHumanImageIn SituIn VitroIndividualInformed ConsentInstitutional Review BoardsLearningLifeLinkMaintenanceMeasuresModelingMusOocytesOperative Surgical ProceduresOrganOrgan Culture TechniquesOrganoidsOvarianOvarian FollicleOvaryPathologicPathologyPerfusionPharmaceutical PreparationsPharmacologic SubstancePhasePhenocopyPhysiologicalPhysiologyPopulationPregnancyProductionReproductive HealthReproductive PhysiologyResearchSamplingSeriesServicesSiteStructureSurfaceSystemTeaching HospitalsTestingTissue PreservationTissue imagingTissuesToxicologyUterusVaccinesVaginaWomanWorkWritingagedbody systemcell typedrug developmentdrug distributionfemale reproductive systemflexibilityhazardhuman embryonic stem cellhuman femalehuman tissueimmortalized cellimprovedin vitro Modelin vivoin vivo Modelmonolayermyometriumoffspringoocyte maturationparacrinepharmacokinetic modelprogramsreproductivereproductive functionreproductive hormonereproductive organreproductive tractresponsescaffoldthree dimensional cell culturetissue culturetoxicanttwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): The female reproductive tract is responsible for producing endocrine hormones, developing mature, healthy gametes (oocytes) and providing the site for fertilization and an environment that supports fetal development. There are five main organs in the female reproductive tract-the ovary, fallopian tubes, uterus, cervix and vagina. Each organ is responsible for unique aspects of reproductive function, but act integrally to support overall endocrine health, fertility, and fetal development. The reproductive tract organs are assembled from multiple cell lineages to create individual follicles (that enclose and support oocytes), oviductal/fallopian tubes, uterine myometrium and endometrium, the cervix and the vagina. Traditionally, research of the female reproductive tract has relied on two-dimensional (2D) cultures of isolated primary cells or immortalized cell lines grown on plastic and independent of adjacent cells, tissue architecture, and functional context. Moving to a three-dimensional (3D) culture environment has allowed us to better understand the function and interaction of cells within individual organs and interrogate interactions between tract tissues in
co-cultures (e.g., the follicle and the ovarian surface cells, or the uterine myometrium and endometrium) to measure responses to normal reproductive hormones, pathologic conditions (such as high levels of androgens) or exposure to endocrine disruptors. New biomaterials and 3D culture systems have now presented us with the exciting opportunity to create a complete in vitro reproductive tract whereby each of the cultured organs can be assembled into a linked perfusion culture system. Just as the biological function and responses of 2D monolayer cell cultures differ from those of 3D-cultured organoids, we predict that the biology of the reproductive organs when studied in an integrated series will more closely recapitulate the in vivo environment. In Aims 1 and 2, we propose to develop in vitro cultures of human reproductive tissues that phenocopy in vivo function in terms of hormone production and response to the physiologically relevant reproductive hormones follicle-stimulating hormone (FSH) and estrogen. We will use the 3DKUBE" culture platform (KIYATEC), which not only permits control of perfusion to mimic tissue circulation, automated sampling for pharmacokinetic analyses, tissue imaging and in situ bioassays, but also will facilitate integration of the individal organ cultures into a functional in vitro female reproductive tract culture system in Aim 3. The successful development of an ex vivo female reproductive tract will give us the unique ability to interrogate normal hormonal responses of each organ in the context of the complete reproductive tract, as well as examine responses of the organs and system to agents that pose reproductive hazards. Toxicologic testing on female reproductive function and fertility is currently limited to animal studies. Our proposed Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System would permit earlier assessment of the effects of drugs, toxicants or vaccines on the human female reproductive system prior to exposure in clinical trials.
描述(由申请人提供):女性生殖道负责产生内分泌激素,发育成熟、健康的配子(卵母细胞),并提供受精的场所和支持胎儿发育的环境。女性生殖道有五个主要器官——卵巢、输卵管、子宫、子宫颈和阴道。每个器官都负责生殖功能的独特方面,但整体上支持整体内分泌健康、生育能力和胎儿发育。生殖道器官由多个细胞系组装而成,形成单个卵泡(包围并支持卵母细胞)、输卵管/输卵管、子宫肌层和子宫内膜、子宫颈和阴道。传统上,女性生殖道的研究依赖于分离的原代细胞或在塑料上生长的永生化细胞系的二维(2D)培养,独立于邻近细胞、组织结构和功能背景。转移到三维(3D)培养环境使我们能够更好地了解单个器官内细胞的功能和相互作用,并询问肠道组织之间的相互作用
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.
- DOI:10.18632/oncotarget.11499
- 发表时间:2016-10-25
- 期刊:
- 影响因子:0
- 作者:Karthikeyan S;Lantvit DD;Chae DH;Burdette JE
- 通讯作者:Burdette JE
Endometriosis and ovarian cancer: links, risks, and challenges faced.
- DOI:10.2147/ijwh.s66824
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Pavone ME;Lyttle BM
- 通讯作者:Lyttle BM
Multidrug Resistance Protein 1 Deficiency Promotes Doxorubicin-Induced Ovarian Toxicity in Female Mice.
多药耐药蛋白 1 缺乏会促进多柔比星诱导的雌性小鼠卵巢毒性。
- DOI:10.1093/toxsci/kfy038
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Wang,Yingzheng;Liu,Mingjun;Zhang,Jiyang;Liu,Yuwen;Kopp,Megan;Zheng,Weiwei;Xiao,Shuo
- 通讯作者:Xiao,Shuo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa K Woodruff其他文献
Making eggs: is it now or later?
做鸡蛋:是现在还是以后?
- DOI:
10.1038/nm1108-1190 - 发表时间:
2008-11-01 - 期刊:
- 影响因子:50.000
- 作者:
Teresa K Woodruff - 通讯作者:
Teresa K Woodruff
Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment
- DOI:
10.1186/scrt374 - 发表时间:
2013-12-01 - 期刊:
- 影响因子:7.300
- 作者:
Monica M Laronda;Joanna E Burdette;J Julie Kim;Teresa K Woodruff - 通讯作者:
Teresa K Woodruff
MALE RESULTS OF THE SPARE STUDY: SURVEY FOR PRESERVATION OF ADOLESCENT REPRODUCTION
- DOI:
10.1016/s0022-5347(08)61917-5 - 发表时间:
2008-04-01 - 期刊:
- 影响因子:
- 作者:
Tobias S Kohler;Sarah Chan;Amul M Shah;Laxmi A Kondapalli;Marybeth Gerrity;Teresa K Woodruff;Robert Brannigan - 通讯作者:
Robert Brannigan
Teresa K Woodruff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa K Woodruff', 18)}}的其他基金
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
- 批准号:
8415387 - 财政年份:2012
- 资助金额:
$ 7.24万 - 项目类别:
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
- 批准号:
8768923 - 财政年份:2012
- 资助金额:
$ 7.24万 - 项目类别:
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
- 批准号:
8730764 - 财政年份:2012
- 资助金额:
$ 7.24万 - 项目类别:
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
- 批准号:
8929340 - 财政年份:2012
- 资助金额:
$ 7.24万 - 项目类别:
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
- 批准号:
9013074 - 财政年份:2012
- 资助金额:
$ 7.24万 - 项目类别:
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
3D 微生理系统中的离体女性生殖道整合
- 批准号:
9105454 - 财政年份:2012
- 资助金额:
$ 7.24万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 7.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 7.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 7.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)